Media about us

• Kaluga eyes new site to produce FDA-approved innovation drugs

  31 July 2013 Marchmont Innovation News

  

  The Kaluga region in Central Russia, the city of Kaluga and NovaMedica, a young Russian pharma, have agreed to build a new pharmaceutical factory in the area, Rusnano  reports . 

• As ReVision Raises $55M, Domain’s Brian Dovey Assesses Rusnano Gambit

  31 July 2013 Bruce V. Bigelow, Xconomy

  

  Almost 18 months ago, Domain Associates and the Russian state technology firm Rusnano agreed to jointly invest as much as $760 million in life sciences deals in the U.S. and Russia. Yesterday, the partners said they have completed their fifth deal—joining a $55 million equity round in ReVision Optics, a Lake Forest, CA-ophthalmic company.

• Rusnano Invests With U.S. Venture Fund

  30 July 2013 The Moscow Times

  

  Rusnano subsidiary RusnanoMednvest and U.S. venture fund Domain Associates have joined a consortium investing $55 million in the U.S. firm ReVision Optics, which is developing technologies to treat age-related vision loss, Interfax reported.

• Domain, Rusnano invest in ReVision

  30 July 2013 BioCentury

  

  Domain Associates and Rusnano, the state-funded $10 billion Russian fund, made their fifth investment under a 2012 investment partnership in Domain portfolio company ReVision Optics Inc. (Lake Forest, Calif.). 

• J&J buys into ReVision Optics' $55M financing round

  30 July 2013 Mark Hollmer, FierceMedicalDevices

  

  ReVision Optics attracted an impressive $55 million in new equity financing from the likes of Johnson & Johnson ($JNJ) and a Russian investor group--a massive cash infusion that will advance its hydrogel eye implant designed to help reduce the need for reading glasses.

• New Russian company to build $85M plant

  30 July 2013 Eric Palmer, FiercePharma Manufacturing

  

  NovaMedica was formed out of Domain Associates' partnership with RUSNANO.

• $85m Plant Demonstrates Russia's Commitment to Pharma 2020, says NovaMedica

  29 July 2013 Dan Stanton, In-Pharma Technologist.com

  

  NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.

• NovaMedica, Kaluga Region and City of Kaluga Sign Agreement on Construction of Pharmaceutical Plant in the Region

  26 July 2013 Reuters

  

  The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.

• NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created

  26 July 2013 BioSpace

  

  The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region. 

• S.Fyodorov Eye Microsurgery Complex and NovaMedica Have Signed a Cooperation Agreement on Localizing Innovative Ophthalmic Treatment Technologies in Russia

  05 June 2013 BioForward

  

  S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.